A Reporter Platform to Study Therapy‐Induced Senescence in Live Cancer Cells
Small Methods · 2025
DOI: 10.1002/smtd.202501270 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, 2025. Verfasst von Jacinta van de Grint und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, 3015 GD, the Netherlan…. Hauptthemen laut MEDLINE: Cellular Senescence, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Oncode Institute.
Abstract (Originalsprache)
Senescence is a durable state of cell cycle arrest that can be induced by various stressors, including DNA damage caused by chemotherapeutic agents or ionizing radiation. In the context of cancer, therapy‐induced senescence (TIS) plays a dual role: while it effectively halts tumor cell proliferation, TIS also carries the risk of promoting tumor relapse through the senescence‐associated secretory phenotype (SASP). Beyond its direct impact on tumor cells, cancer therapies leading to TIS often induce short‐ and long‐term side effects that significantly affect the quality of life for patients. However, the lack of universal biomarkers for TIS hinders a comprehensive understanding of its characteristics and its role in cancer therapies. A lamin‐based senescence reporter platform is developed to reliably detect and sort live senescent cancer cells. This versatile tool supports live‐cell imaging, enabling real‐time tracking of senescence induction and escape to investigate heterogeneity in treatment response. Additionally, it allows high‐content screening and marker integration, for example incorporating IL6 as SASP marker. It is therefore a valuable tool for fundamental research addressing new questions in the field of TIS as well as for drug discovery, including the development of novel senolytics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, 3015 GD, the Netherlands.
- Department of Pathology, Erasmus University Medical Center, Rotterdam, 3015 GD, the Netherlands.
ORCID-Profile: Maayke M P Kuijten
Förderung
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Oncode Institute
Zitieren
APA
van de Grint, J., Huang, M., Sangers, R., Odijk, H., Reuvers, T., Heredia-Genestar, J. M., Raams, A., Kan, T. W., Pothof, J., Kanaar, R., & Kuijten, M. M. P. (2025). A Reporter Platform to Study Therapy‐Induced Senescence in Live Cancer Cells. Small Methods. https://doi.org/10.1002/smtd.202501270
Vancouver
van de Grint J, Huang M, Sangers R, Odijk H, Reuvers T, Heredia-Genestar JM, et al. A Reporter Platform to Study Therapy‐Induced Senescence in Live Cancer Cells. Small Methods. 2025. doi:10.1002/smtd.202501270
BibTeX
@article{vandeGrint2025,
author = {van de Grint, Jacinta and Huang, Mengqi and Sangers, Ruben and Odijk, Hanny and Reuvers, Thom and Heredia-Genestar, Jose M and Raams, Anja and Kan, Tsung Wai and Pothof, Joris and Kanaar, Roland and Kuijten, Maayke M P},
title = {A Reporter Platform to Study Therapy‐Induced Senescence in Live Cancer Cells},
journal = {Small Methods},
year = {2025},
doi = {10.1002/smtd.202501270}
}
EUVIMED